miR | Chr | Monosomy-3 vs. disomy-3a fold difference | Monosomy-3 vs. disomy-3a P | Metastatic vs. nonmetastaticb P | Plasma levelsc | |
---|---|---|---|---|---|---|
Monosomy-3 | Disomy-3 | |||||
Over-expressed in tumors with monosomy-3 | ||||||
 hsa-miR-135a* | 3 | 80 | 0.0003 | NS | ND | ND |
 hsa-miR-624 | 14 | 7.6 | 0.0003 | 0.0004 | ND | ND |
 hsa-miR-449b | 5 | 5.9 | 0.0005 | NS | ND | ND |
 hsa-miR-142-5p | 17 | 7.5 | 0.0006 | NS | 1236 | 1059 |
 hsa-miR-92b | 1 | 2.9 | 0.0009 | NS | 688 | ND |
 hsa-miR-628-5p | 15 | 4.8 | 0.001 | NS | ND | ND |
Under-expressed in tumors with monosomy-3 | ||||||
 hsa-miR-509-3-5p | X | 615 | 0.00000008 | 0.0002 | ND | ND |
 hsa-miR-508-3p | X | 4672 | 0.0000003 | 0.0004 | ND | ND |
 hsa-miR-514 | X | 2887 | 0.0000009 | NS | ND | ND |
 hsa-miR-506 | X | 1308 | 0.000001 | 0.0008 | ND | ND |
 hsa-miR-513a-5p | X | 1674 | 0.000002 | 0.001 | ND | ND |
 hsa-miR-507 | X | 61 | 0.000003 | NS | ND | ND |
 hsa-miR-509-3p | X | 818 | 0.000004 | 0.0008 | ND | ND |
 hsa-miR-513b | X | 75 | 0.00003 | 0.00002 | ND | ND |
 hsa-miR-876-3p | 9 | 81 | 0.00003 | NS | ND | ND |
 hsa-miR-378* | 5 | 5.1 | 0.0002 | NS | ND | ND |
 hsa-miR-935 | 19 | 4.1 | 0.0003 | 0.001 | ND | ND |
 hsa-miR-181a | 9 | 7.4 | 0.0004 | NS | 546 | ND |
 hsa-miR-99a | 21 | 5.6 | 0.0009 | NS | ND | ND |
 hsa-miR-194 | 1 | 4.5 | 0.001 | NS | ND | ND |
 hsa-miR-592 | 7 | 4.1 | 0.001 | NS | ND | ND |
 hsa-miR-1296 | 10 | 15 | 0.001 | NS | ND | ND |
 hsa-miR-624* | 14 | 7.5 | 0.002 | NS | ND | ND |
 hsa-miR-140-5p | 16 | 10 | 0.002 | NS | ND | ND |
 hsa-miR-651 | X | 6.1 | 0.002 | NS | ND | ND |